Assessing CMPI potentiation of (α4)3(β2)2 nicotinic acetylcholine receptor using the Monod-Wyman-Changeux allosteric model

被引：0
|
作者：
Deba, Farah [1 ]
Akk, Gustav [2 ]
Hamouda, Ayman [1 ]
机构：
[1] Univ Texas Tyler, Tyler, TX 75799 USA
[2] Washington Univ, St Louis, MO 14263 USA
来源：
FASEB JOURNAL | 2020年 / 34卷
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1096/fasebj.2020.34.s1.03706
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Methadone is a Non-Competitive Antagonist at the α4β2 and α3*Nicotinic Acetylcholine Receptors and an Agonist at the α7 Nicotinic Acetylcholine Receptor
    Talka, Reeta
    Salminen, Outi
    Tuominen, Raimo K.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2015, 116 (04) : 321 - 328
  • [32] Discovery of Potent Positive Allosteric Modulators of the α3β2 Nicotinic Acetylcholine Receptor by a Chemical Space Walk in ChEMBL
    Buergi, Justus J.
    Awale, Mahendra
    Boss, Silvan D.
    Schaer, Tifany
    Marger, Fabrice
    Viveros-Paredes, Juan M.
    Bertrand, Sonia
    Gertsch, Juerg
    Bertrand, Daniel
    Reymond, Jean-Louis
    ACS CHEMICAL NEUROSCIENCE, 2014, 5 (05): : 346 - 359
  • [33] Structural determinants of α4β2 nicotinic acetylcholine receptor trafficking
    Ren, XQ
    Cheng, SB
    Treuil, MW
    Mukherjee, J
    Rao, J
    Braunewell, KH
    Lindstrom, JM
    Anand, R
    JOURNAL OF NEUROSCIENCE, 2005, 25 (28): : 6676 - 6686
  • [34] In Silico Models for the Human α4β2 Nicotinic Acetylcholine Receptor
    Haddadian, Esmael J.
    Cheng, Mary Hongying
    Coalson, Rob D.
    Xu, Yan
    Tang, Pei
    JOURNAL OF PHYSICAL CHEMISTRY B, 2008, 112 (44): : 13981 - 13990
  • [35] The α5 Nicotinic Acetylcholine Receptor Subunit Differentially Modulates α4β2*and α3β4*Receptors
    Scholze, Petra
    Huck, Sigismund
    FRONTIERS IN SYNAPTIC NEUROSCIENCE, 2020, 12
  • [36] Single-channel properties of α3β4, α3β4α5 and α3β4β2 nicotinic acetylcholine receptors in mice lacking specific nicotinic acetylcholine receptor subunits
    Ciuraszkiewicz, Anna
    Schreibmayer, Wolfgang
    Platzer, Dieter
    Orr-Urtreger, Avi
    Scholze, Petra
    Huck, Sigismund
    JOURNAL OF PHYSIOLOGY-LONDON, 2013, 591 (13): : 3271 - 3288
  • [37] Allosteric modulation of alpha4beta2 nicotinic acetylcholine receptors by HEPES
    Weltzin, Maegan M.
    Huang, Yanzhou
    Schulte, Marvin K.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2014, 732 : 159 - 168
  • [38] Galantamine is not a positive allosteric modulator of human α4β2 or α7 nicotinic acetylcholine receptors
    Kowal, Natalia M.
    Ahring, Philip K.
    Liao, Vivian W. Y.
    Indurti, Dinesh C.
    Harvey, Benjamin S.
    O'Connor, Susan M.
    Chebib, Mary
    Olafsdottir, Elin S.
    Balle, Thomas
    BRITISH JOURNAL OF PHARMACOLOGY, 2018, 175 (14) : 2911 - 2925
  • [39] Pharmacological Characterization of the Allosteric Modulator Desformylflustrabromine and Its Interaction with α4β2 Neuronal Nicotinic Acetylcholine Receptor Orthosteric Ligands
    Weltzin, Maegan M.
    Schulte, Marvin K.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 334 (03): : 917 - 926
  • [40] Potentiation of (α4)2(02)3, but not (α4)3(02)2, nicotinic acetylcholine receptors reduces nicotine self-administration and withdrawal symptoms*
    Hamouda, Ayman K.
    Bautista, Malia R.
    Akinola, Lois S.
    Alkhlaif, Yasmin
    Jackson, Asti
    Carper, Moriah
    Toma, Wisam B.
    Garai, Sumanta
    Chen, Yen-Chu
    Thakur, Ganesh A.
    Fowler, Christie D.
    Damaj, M. Imad
    NEUROPHARMACOLOGY, 2021, 190
12345